Dr Emma Catt Sharman, | |
1802 6th Ave S, Birmingham, AL 35233-1932 | |
(205) 934-3411 | |
Not Available |
Full Name | Dr Emma Catt Sharman |
---|---|
Gender | Female |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 3 Years |
Location | 1802 6th Ave S, Birmingham, Alabama |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124602941 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163W00000X | Registered Nurse | 1-150265 (Alabama) | Secondary |
367500000X | Nurse Anesthetist, Certified Registered | 1-150265 (Alabama) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of Alabama Hospital | Birmingham, AL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Alabama Health Services Foundation, Pc | 1951213107 | 2344 |
News Archive
Higher coronary artery calcium levels in middle-age were associated with structural heart abnormalities linked to future heart failure, particularly among blacks, according to new research in Circulation: Cardiovascular Imaging, an American Heart Association journal.
DentalVibe™ a new dental device now on the market takes the fear and pain out of dental injections. The product design firm, Bresslergroup, teamed with Dr. Steven G. Goldberg, DDS, to design the easy to use tool. Research shows that fear of a painful anesthetic injection keeps 50% of the patient population away from the dentist.
Gilead Sciences, Inc. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for marketing approval of the "Quad", a complete single-tablet regimen of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate for the treatment of HIV-1 infection in adults.
Recent developments have greatly improved the understanding of the mechanisms used by cells to identify and repair breaks in DNA, and the potential for drugs that target DNA repair in the treatment of a range of human diseases including cancer.
PolyTouch Medical Ltd., a leading developer of laparoscopic hernia mesh placement technologies, today announced that it has filed a Premarket 510(k) Application with the US Food and Drug Administration for PatchAssist, an Innovative Laparoscopic Mesh Deployment and Placement Device that enables accurate mesh placement in laparoscopic ventral hernia repair potentially reducing procedure time by 30%-50%.
› Verified 6 days ago
Entity Name | University Of Alabama Health Services Foundation, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
Higher coronary artery calcium levels in middle-age were associated with structural heart abnormalities linked to future heart failure, particularly among blacks, according to new research in Circulation: Cardiovascular Imaging, an American Heart Association journal.
DentalVibe™ a new dental device now on the market takes the fear and pain out of dental injections. The product design firm, Bresslergroup, teamed with Dr. Steven G. Goldberg, DDS, to design the easy to use tool. Research shows that fear of a painful anesthetic injection keeps 50% of the patient population away from the dentist.
Gilead Sciences, Inc. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for marketing approval of the "Quad", a complete single-tablet regimen of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate for the treatment of HIV-1 infection in adults.
Recent developments have greatly improved the understanding of the mechanisms used by cells to identify and repair breaks in DNA, and the potential for drugs that target DNA repair in the treatment of a range of human diseases including cancer.
PolyTouch Medical Ltd., a leading developer of laparoscopic hernia mesh placement technologies, today announced that it has filed a Premarket 510(k) Application with the US Food and Drug Administration for PatchAssist, an Innovative Laparoscopic Mesh Deployment and Placement Device that enables accurate mesh placement in laparoscopic ventral hernia repair potentially reducing procedure time by 30%-50%.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Emma Catt Sharman, 125 Stone Hill Cir, Pelham, AL 35124-3936 Ph: (205) 223-9817 | Dr Emma Catt Sharman, 1802 6th Ave S, Birmingham, AL 35233-1932 Ph: (205) 934-3411 |
News Archive
Higher coronary artery calcium levels in middle-age were associated with structural heart abnormalities linked to future heart failure, particularly among blacks, according to new research in Circulation: Cardiovascular Imaging, an American Heart Association journal.
DentalVibe™ a new dental device now on the market takes the fear and pain out of dental injections. The product design firm, Bresslergroup, teamed with Dr. Steven G. Goldberg, DDS, to design the easy to use tool. Research shows that fear of a painful anesthetic injection keeps 50% of the patient population away from the dentist.
Gilead Sciences, Inc. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for marketing approval of the "Quad", a complete single-tablet regimen of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate for the treatment of HIV-1 infection in adults.
Recent developments have greatly improved the understanding of the mechanisms used by cells to identify and repair breaks in DNA, and the potential for drugs that target DNA repair in the treatment of a range of human diseases including cancer.
PolyTouch Medical Ltd., a leading developer of laparoscopic hernia mesh placement technologies, today announced that it has filed a Premarket 510(k) Application with the US Food and Drug Administration for PatchAssist, an Innovative Laparoscopic Mesh Deployment and Placement Device that enables accurate mesh placement in laparoscopic ventral hernia repair potentially reducing procedure time by 30%-50%.
› Verified 6 days ago
Ladana M. Williams, C.R.N.A. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 701 Princeton Ave Sw, Birmingham, AL 35211 Phone: 205-783-3144 | |
James M. Hatchett, CRNA Nurse Anesthetist - CR Medicare: May Accept Medicare Assignments Practice Location: 701 Princeton Ave Sw, Birmingham, AL 35211 Phone: 205-977-1949 | |
Katherine S. Thompson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 701 Princeton Ave Sw, Birmingham, AL 35211 Phone: 205-977-1949 | |
Karen Barrow, CRNA Nurse Anesthetist - CR Medicare: May Accept Medicare Assignments Practice Location: 2010 Brookwood Medical Ctr Dr, Birmingham, AL 35209 Phone: 205-877-1000 | |
Brooklyn Williams, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2010 Brookwood Medical Ctr Dr, Birmingham, AL 35209 Phone: 205-877-1000 | |
Robert Singley, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 800 Montclair Rd, Birmingham, AL 35213 Phone: 205-783-3144 | |
Dr. Andrew Paul Nolen, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1802 6th Ave S, Birmingham, AL 35233 Phone: 205-934-3411 |